Capecitabine, DNA synthesis inhibitor
Be the first to review this product! Submit a review
|
(3 Publications)
MW 359.35 Da, Purity >99%. Selective, novel oral fluoropyrimidine carbamate. Prodrug of 5-Fluorouracil (ab142387). Anticancer agent. Active in vitro and in vivo.
View Alternative Names
IMD42, MGC129539, NR1F3, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group F member 3, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-related orphan receptor C, RORG_HUMAN, RZR GAMMA, RZRG, Retinoic acid binding receptor gamma, Retinoid-related orphan receptor-gamma, Rorc, TOR
Product details
Properties and storage information
Shipped at conditions
Appropriate long-term storage conditions
Storage information
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Oncotarget 7:7715-31 PubMed26735339
2016
Applications
Unspecified application
Species
Unspecified reactive species
Cancer letters 349:128-35 PubMed24746899
2014
Applications
Unspecified application
Species
Unspecified reactive species
European journal of cancer (Oxford, England : 1990) 34:1274-81 PubMed9849491
1998
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com